PETAH TIKVA, Israel, Sept. 6 2018 /PRNewswire/ — Leviticus Cardio, inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) system for use with implanted left ventricular assist devices (LVADs), announces the successful completion of a 90-day preclinical chronic animal study to evaluate its […]
Tag: LVAD
Leviticus Cardio Confirms the Successful Completion of a Long-term Chronic Animal Study
PETAH TIKVA, Israel, April 10, 2018 /PRNewswire/ — Leviticus Cardio, the inventor of wireless power transfer for Left Ventricular Assisted Devices, or “LVADs”, for patients with severe cardiac issues, has announced another round of successful animal trials, well beyond periods required to demonstrate suitability […]
New Long-Term Data Show Improved Survival and Lower Rates of Stroke and Pump Thrombosis for Abbott’s HeartMate 3 Heart Pump
ORLANDO, Fla., March 11, 2018 /PRNewswire/ — Abbott (NYSE: ABT) announced new late-breaking clinical trial data from the MOMENTUM 3 clinical study, the largest left ventricular assist device (LVAD) trial in the world to evaluate patients in need of both short-term and long-term […]
CorInnova Wins Top Prize at “RESI San Francisco 2018” Innovation Challenge
HOUSTON–(BUSINESS WIRE)–CorInnova Inc., an emerging medical device company developing breakthrough technology for the treatment of Heart Failure, announced today that it has won First Prize in the “RESI (Redefining Early Stage Investments) San Francisco 2018” investment competition for early-stage life science […]
The Ethical Quandary of LVAD Disconnection
By Ken Dropiewski, Prime-Core Executive Search (ken@prime-core.com) New research brings to light a question of ethics when it comes to the deactivation of a left ventricular assist device (LVAD). Concerns differ significantly between cardiologists, hospice, and palliative medicine clinicians. This […]
Abbott (ABT) Introduces Heartmate 3 Left Ventricular Assist System – The Latest Milestone In Therapy For Advanced Heart Failure Patients
ABBOTT PARK, Ill., Aug. 28, 2017 /PRNewswire/ — Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left Ventricular Assist System (also known as an LVAD). The HeartMate 3 system provides a new […]
Millar, Inc. Sells Inca® Pressure-Volume (PV) Loop System to the University of Colorado to Support LVAD Research
HOUSTON, June 22, 2017 /PRNewswire/ — Millar, Inc. is pleased to announce that the University of Colorado Anschutz Medical Campus has purchased the CD Leycom® Inca® Pressure-Volume (PV) Loop System – sold in North America exclusively by Millar, Inc. – to better […]